Coordinated expression of cyclin-dependent kinase-4 and its regulators in human oral tumors

Anticancer Research

Volumn 34, Issue 7, 2014, Pages 3285-3292

  Poi, Ming J ^a,b   Knobloch, Thomas J ^a,b   Sears, Marta T ^b   Uhrig, Lana K ^b   Warner, Blake M ^b   Weghorst, Christopher M ^a,b,c   Li, Junan ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Coordination; Cyclin dependent kinase 4; Squamous cell carcinoma of the head and neck; Transcription up regulation

Indexed keywords

BMI1 PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN E; GANKYRIN; PROTEIN; SE11 PROTEIN; UNCLASSIFIED DRUG; CCND1 PROTEIN, HUMAN; CDK4 PROTEIN, HUMAN; MAPK7 PROTEIN, HUMAN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 7; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEASOME; PSMD10 PROTEIN, HUMAN; SERTAD1 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER GROWTH; CANCER RISK; CARCINOGENESIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MALE; ORAL BIOPSY; PAPILLOMAVIRUS INFECTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING; TOBACCO USE; UPREGULATION; BIOSYNTHESIS; CASE CONTROL STUDY; COORDINATION; ENZYMOLOGY; GENETICS; HEAD AND NECK TUMOR; METABOLISM; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; PRINCIPAL COMPONENT ANALYSIS; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK; TRANSCRIPTION UP-REGULATION;

COORDINATION; CYCLIN-DEPENDENT KINASE 4; SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK; TRANSCRIPTION UP-REGULATION;

ADULT; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE 4; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 7; MOUTH NEOPLASMS; NUCLEAR PROTEINS; PRINCIPAL COMPONENT ANALYSIS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; TRANS-ACTIVATORS; UP-REGULATION;

EID: 84906346223     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Li J, Poi MJ and Tsai MD: Regulatory mechanisms of tumor suppressor P16INK4A and their relevance to cancer. Biochemistry 50: 5566-5582, 2011.
2. Sherr CJ and McCormick F: The RB and p53 pathways in cancer. Cancer Cell 2: 103-112, 2002.
3. Kim WY and Sharpless NE: The regulation of INK4/ARF in cancer and aging. Cell 127: 265-275, 2006.
4. Ortega S, Malumbres M and Barbacid M: Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 1602: 73-87, 2002.
5. Ozaki T and Nakagawara A: Role of p53 in cell death and human cancers. Cancers 3: 994-1013, 2011.
6. Sherr CJ and Roberts JM: Living with or without cyclins and cyclin-dependent kinases. Genes Dev 18: 2699-2711, 2004.
7. Li J and Tsai MD: Novel insights into the INK4-CDK4/6-Rb pathway: counter action of gankyrin against INK4 proteins regulates the CDK4-mediated phosphorylation of Rb. Biochemistry 41: 3977-3983, 2002.
8. Hsu SI, Yang CM, Sim KG, Hentschel DM, O'Leary E and Bonventre JV: TRIP-Br: a novel family of PHD zinc finger- and bromodomain-interacting protein that regulate the transcriptional activity of E2F-1/DP-1. EMBO J 21: 2273-2285, 2001.
9. Li J, Melvin WS, Tsai MD, Weghorst CM and Muscarealla P: The nuclear protein p34SEI-1 regulates the kinase activity of cyclin-dependent kinase 4 in a concentration-dependent manner. Biochemistry 43: 4394-4399, 2004.
10. Agherbi H, Gaussmann-Wenger A, Verthuy C, Chasson L, Serrano M and Djabali M: Polycomb mediated epigenetic silencing and replication timing at the INK4a/ARF locus during senescence. PLoS One 4: e5622, 2009.
11. Siu KT, Rosner MR and Minella AC: An integrated view of cyclin E function and regulation. Cell Cycle 11: 57-64, 2012.
12. Nakayama N, Nakayama K, Shamima Y, Ishikawa M, Katagiri A, Iida K and Miyazaki K: Gene amplification of CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer. Cancer 116: 2621-2634, 2010.
13. Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA and Sutherland RL: Expression and amplification of cyclin genes in human breast cancer. Oncogene 8: 2127-2133, 1993.
14. Peurala E, Koivunen P, Haapasaari K-M, Bloigu R and Jukkola-Vuorinen A: The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer. Breast Cancer Res 15: R5, 2013.
15. Higashitsuji H, Itoh K, Nagao T, Dawson S, Nonoguchi K, Kido T, Mayer RJ, Arii S and Fujita J: Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. Nat Med 6: 96-99, 2000.
16. Li J, Knobloch TJ, Kresty LA, Zhang Z, Lang JC, Schuller DE and Weghorst CM: Gankyrin, an epithelial biomarker, is frequently over-expressed in human oral cancers. Anticancer Res 31: 2683-2692, 2011.
17. Tang TC, Sham JS, Xie D, Fang Y, Huo KK, Wu QL and Guan XY: Identification of a candidate oncogene SEI-1 within a minimal amplified region at 19q13.1 in ovarian cancer cell lines. Cancer Res 62: 7157-7161, 2002.
18. Li Y, Nie CJ, Hu L, Qin Y, Liu HB, Zeng TT, Chen L, Fu L, Deng W, Chen SP, Jia WH, Zhang C, Xie D and Guan XY: Characterization of a novel mechanism of genomic instability involving the SEI1/SET/NM23H1 pathway in esophageal cancers. Cancer Res 70: 5695-5705, 2010.
19. Hong SW, Kim CJ, Park WS, Shin JS, Lee SD, Ko SG, Jung SI, Park IC, An SK, Lee WK, Lee WJ, Jin DH and Lee MS: p34SEI-1 inhibits apoptosis through the stabilization of the X-linked inhibitor of apoptosis protein: p34SEI-1 as a novel target for anti-breast cancer strategies. Cancer Res 69: 741-746, 2009.
20. Siddique HR and Salem M: Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences. Stem Cells 30: 372-378, 2012.
21. Cao L, Bombard J, Cintron K, Sheedy J, Weetall ML and Davis TW: BMI1 as a novel target for drug discovery in cancer. J Cell Biochem 112: 2729-2741, 2011.
22. INK4/ARF-mediated en bloc regulation of the INK4-ARF locus in human squamous cell carcinoma of the head and neck. Mol Carcinogenesis, DOI:10.1002/mc.22119 [Epub ahead of print], 2013.
23. 16INK4A/CDKN2A alterations in chemically induced Syrian golden hamster pancreatic tumors. Carcinogenesis 25: 263-268, 2004.
24. Maitland NJ, Bromidge T, Cox MF, Crane IJ, Prime SS and Scully C: Detection of human papillomavirus genes in human oral tissue biopsies and cultures by polymerase chain reaction. Br J Cancer 59: 698-703, 1989.
25. Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3: 1101-1108, 2008.
26. American cancer Society. Cancer Facts and Figures 2012. Atlanta, GA: American Cancer Society 2012.
27. Roy PG and Thompson AM: Cyclin D1 and breast cancer. Breast 15: 718-727, 2006.
28. Li J, Muscarella P, Joo SH, Knobloch TJ, Melvin WS, Weghorst CM and Tsai MD: Dissection of CDK4-binding and transactivation activities of p34SEI-1 and comparisons between functions of p34SEI-1 and p16INK4A. Biochemistry 44: 13246-13256, 2005.
29. An HX, Beckmann MW, Reifenberger G, Bender HG and Niederacher D: Gene amplification and overexpression of Cdk4 in sporadic breast carcinomas is associated with high tumor cell proliferation. Am J Pathol 154: 113-118, 1999.
30. Musgrove EA, Caldon CE, Barraclough J, Stone A and Sutherland RL: Cyclin D as a therapeutic target in cancer. Nat Rev Cancer 11: 558-572, 2011.
31. Sim KG, Zang Z, Yang CM, Boventre JV and Hsu SI: TRIP-Br links E2F to novel functions in the regulation of cyclin E expression during cell cycle progression and in the maintenance of genomic stability. Cell Cycle 3: 1296-1304, 2004.
32. Polanska H, Raudenska M, Gumulec J, Sztalmachova M, Adam V, Kizek R and Masarik M: Clinical significance of head and neck squamous cell cancer biomarkers. Oral Oncol 50: 168-177, 2014.
33. Leemans CR, Braakhuis BJ and Brakenhoff RH: The molecular biology of head and neck cancer. Nat Rev Cancer 11: 9-22, 2011.
34. van Oijen MG and Slootweg PJ: Oral field cancerization: Carcinogen-induced independent events or micrometastatic deposits? Cancer Epidemiol Biomarkers Prev 9: 249-256, 2000.
35. Angadi PV, Savitha JK, Rao SS, and Sivaranjini: Oral field cancerization: current evidence and future perspective. Oral Maxillofac Surg 16: 171-180, 2012.
36. Priante AV, Castilho EC, and Kowalski LP: Second primary tumors in patients with head and neck cancer. Curr Oncol Rep 13: 132-137, 2011.
37. da Silva SD, Hier M, Mlynarek A, Kowalski LP, and Alaoui-Jamali MA: Recurrent oral cancer: current and emerging therapeutic approaches. Front Pharmacol 3: 149, 2012.